z-logo
open-access-imgOpen Access
Low Molecular Weight Heparin Inhibits Circulating Fibrocytes Differentiation by Modulating Neuronal Nitric Oxide Synthase and TGF-�1/Smad Pathway
Author(s) -
Xudong Xie,
Liangfeng Zhu,
Zhongying Fu,
Xiaogang Guo,
Kan Wang,
Xiaosheng Hu,
Jun-zhu Chen
Publication year - 2012
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000343334
Subject(s) - smad , transdifferentiation , western blot , flow cytometry , nitric oxide synthase , chemistry , nitric oxide , endocrinology , blot , gene isoform , medicine , transforming growth factor , microbiology and biotechnology , biology , biochemistry , stem cell , gene
Circulating fibrocytes (CFs) have been placed at the center of a number of fibrosing conditions. Recently, attention has been drawn to the non-anticoagulant activities of low molecular weight heparin (LH), especially its anti-fibrotic effects. The purpose of this study was to investigate the effects of LH on CFs differentiation and possible underlying mechanisms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom